This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
DrugPatentWatch can help identify generic entrants at the earliest stages Many clients come to DrugPatentWatch seeking to identify generic entrants well before they launch. CDMOs, equipment manufacturers, regulatory consultants, and…. The post Customer Success: How do we identify generic entrants before they get FDA approval? appeared first on DrugPatentWatch - Make Better Decisions.
To succeed in today’s highly competitive pharmaceutical landscape, differentiation is key. In recent years, many. The post The Opportunity for Generics Companies and Value Added Medicines in the US and Europe appeared first on Camargo.
STEPS TO START A PHARMACEUTICAL DISTRIBUTION COMPANY. When the pharma secto r is touching new heights year after year, it is a great idea to take the business benefits from it. Due to technological and scientific advances, pharmaceutical innovations are happening every second day. It means the opportunities are more than ever, especially if you are an enthusiastic entrepreneur.
At first, it may seem like your diagnosis only changes the big things – you now have to manage a chronic illness, adjust your treatment as needed, learn to recognise symptoms, be prepared for a myasthenic crisis , etc. Fatigue makes everyday life harder and you may feel frustrated, ashamed or vulnerable for needing assistance with simple tasks that took no effort before. .
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Meeting Metrics As A CRA In this episode we discuss what metrics CRA's have to meet. As many of you know Clinical Research Associates are very busy but why is that? The metrics they have to meet are a big reason for that. Stay tuned for an upcoming episode on the metric differences between the pharma world and CRO world. Don't forget to Subscribe for new content!
This week, journalist Ben Elgin of Bloomberg published an exceedingly thorough and investigative report about how the Partnership for Safe Medicines (PSM), funded by the Pharmaceutical Researchers and Manufacturers of America (PhRMA), is behind a massive campaign to defeat drug importation proposals that seek to lower drug prices. In fact, the report disclosed that PSM apparently received $7 million in 2017 to oppose importation.
Meeting Metrics As A CRA. In this episode we discuss what metrics CRA's have to meet. As many of you know Clinical Research Associates are very busy but why is that? The metrics they have to meet are a big reason for that. Stay tuned for an upcoming episode on the metric differences between the pharma world and CRO world. Don't forget to Subscribe for new content!
Meeting Metrics As A CRA. In this episode we discuss what metrics CRA's have to meet. As many of you know Clinical Research Associates are very busy but why is that? The metrics they have to meet are a big reason for that. Stay tuned for an upcoming episode on the metric differences between the pharma world and CRO world. Don't forget to Subscribe for new content!
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content